Clinical Decision Support¶

Evidence-based treatment recommendations, drug interaction alerts, and clinical pathway adherence optimization.

Priority: P0 — Immediate ROI
Time to Value: 4-6 weeks
Category: Clinical Intelligence

Business Problem¶

Clinicians face an explosion of medical knowledge — with 3,000+ clinical guidelines and 20,000+ drug interactions to navigate — while managing increasing patient volumes under time pressure:

Information overload — physicians cannot keep up with the latest evidence-based guidelines across every condition they treat
Adverse drug events (ADEs) — drug-drug interactions, dosing errors, and allergy contraindications cause 1.3M injuries annually in the US, many preventable with better decision support
Protocol variation — clinicians treating the same condition follow different protocols, leading to inconsistent outcomes and increased cost
Alert fatigue — existing EHR alerts fire too frequently (>90% overridden), burying critical alerts in noise
Diagnostic delay — abnormal lab results and imaging findings sometimes go unacknowledged for days, delaying treatment for time-sensitive conditions
Unnecessary testing — duplicate orders and low-value diagnostics add cost without clinical benefit

Capabilities¶

Intelligent Drug Interaction & Allergy Checking¶

Context-aware medication safety checks that go beyond basic drug-drug interaction lists — considering patient-specific factors (renal function, age, weight, comorbidities) to reduce alert fatigue while catching genuinely dangerous interactions.

Evidence-Based Treatment Recommendations¶

AI-powered clinical pathway suggestions based on patient diagnosis, comorbidities, prior treatments, and current guidelines — surfaced within clinician workflow at the point of care.

Critical Result Management¶

Automated detection and escalation of critical lab results, imaging findings, and clinical deterioration patterns (early warning scores) to ensure no abnormal result goes unacknowledged.

Diagnostic Order Optimization¶

Identify duplicate orders, recommend bundled test panels, and flag low-value diagnostics based on clinical context — reducing unnecessary testing while ensuring diagnostic completeness.

Sepsis & Deterioration Early Warning¶

Real-time monitoring of vital signs, lab trends, and nursing assessments to predict sepsis, respiratory failure, and other clinical deterioration events 4-12 hours before clinical manifestation.

Data Sources & Ontology Mapping¶

flowchart LR
    subgraph Data Plane
        EHR["EHR / EMR"]
        IMAGING["Imaging & Lab"]
        NOTES["Clinical Notes"]
    end

    subgraph Ontology Entities
        PATIENT["Patient Context"]
        MEDS["Medications & Allergies"]
        LABS["Lab Results & Vitals"]
        ORDERS["Clinical Orders"]
        EVIDENCE["Clinical Guidelines"]
    end

    subgraph AI Workflow
        SAFETY["Medication Safety"]
        PATHWAY["Pathway Engine"]
        CRITICAL["Critical Result Monitor"]
        EWS["Early Warning System"]
    end

    EHR --> PATIENT
    EHR --> MEDS
    EHR --> ORDERS
    IMAGING --> LABS
    NOTES --> PATIENT

    MEDS --> SAFETY
    PATIENT --> SAFETY
    PATIENT --> PATHWAY
    EVIDENCE --> PATHWAY
    LABS --> CRITICAL
    LABS --> EWS
    PATIENT --> EWS

Ontology Entity	Source System	Key Fields
Patient Context	EHR + Clinical Notes	Age, Weight, Diagnoses, Comorbidities, Renal Function (eGFR), Liver Function, Pregnancy Status
Medications & Allergies	EHR MAR / Pharmacy	Drug Name, Dose, Route, Frequency, Start Date, Allergies, Prior ADEs
Lab Results & Vitals	EHR + LIS	Test Name, Result Value, Reference Range, Critical Flag, Timestamp, Trend
Clinical Orders	EHR CPOE	Order Type, Test/Procedure, Priority, Ordering Provider, Indication, Status
Clinical Guidelines	Knowledge Base (UpToDate, NCCN, ADA)	Condition, Guideline Source, Recommendation, Evidence Level, Last Updated

AI Workflow¶

Patient Context Assembly — Build real-time patient context: active diagnoses, current medications, allergies, renal/hepatic function, vitals, and relevant NLP-extracted findings from clinical notes
Medication Safety Scoring — For each new medication order, evaluate against: drug-drug interactions weighted by patient context (renal dose adjustment needed?), allergy cross-reactivity, duplicate therapy, and age/weight-based dosing
Alert Prioritization — Score each alert by clinical severity × patient-specific risk to reduce alert fatigue; suppress low-risk alerts (override rate >95% historically) and prominently display high-risk alerts
Pathway Matching — Map patient's condition + comorbidity profile to the most relevant clinical pathway; highlight deviations from evidence-based recommendations in current treatment plan
Critical Result Detection — Monitor incoming lab results and imaging reports; flag results exceeding critical thresholds or showing significant acute changes; escalate to ordering provider with auto-paging if unacknowledged within configured timeframe
Deterioration Prediction — Continuous scoring using modified early warning score (MEWS) + ML model incorporating vital sign trends, lab changes, and nursing assessment patterns to predict clinical deterioration 4-12 hours ahead
Output — Medication safety alerts in EHR order entry; pathway recommendations in clinical workflow; critical result notifications to providers; deterioration alerts to rapid response team

Dashboard & Alerts¶

Key Metrics¶

KPI	Description	Target
Adverse Drug Event Rate	ADEs per 1,000 patient-days	< 2.0 (down from 5-8)
Alert Override Rate	% of CDS alerts overridden by clinicians	< 70% (down from 92%)
Clinical Pathway Adherence	% of patients managed per evidence-based pathway	> 80%
Critical Result Acknowledgment Time	Minutes from result to provider acknowledgment	< 30 min (100% within 60 min)
Sepsis Bundle Compliance	% of sepsis cases with 3-hour bundle completed on time	> 85%
Unnecessary Test Rate	% of orders flagged as duplicate or low-value	< 8% (down from 15%)

Alert Rules¶

Alert	Trigger	Severity	Action
Critical drug interaction	High-severity interaction with patient-specific risk factors	Critical	Interruptive alert in CPOE; require clinical justification to proceed
Sepsis prediction	ML sepsis risk score exceeds threshold with supporting clinical indicators	Critical	Page rapid response team; auto-order sepsis bundle labs if protocol allows
Critical lab result	Result exceeds critical threshold (e.g., K+ > 6.5, Troponin > 5x ULN)	Critical	Auto-page ordering provider; escalate to covering physician if unacknowledged in 15 min
Pathway deviation	Treatment plan deviates from recommended pathway for >48 hours	Medium	Non-interruptive recommendation to attending physician
Duplicate order	Same diagnostic test ordered within clinically inappropriate window	Medium	Soft-stop alert suggesting prior result availability

ROI Model¶

Metric	Before	After	Impact
Adverse drug events	6.2 per 1,000 patient-days	3.1 per 1,000 patient-days	50% reduction → $4.8M avoided costs (ADE costs $3-5K each)
Alert fatigue (override rate)	92% of alerts overridden	68%	26% improvement → safer care
Unnecessary testing	15% of orders low-value	7% of orders	53% reduction → $2.1M savings
Sepsis mortality improvement	22% mortality	16% mortality	27% reduction → lives saved
Critical result TAT	55 min average	18 min average	67% faster → better outcomes

Estimated Annual ROI

$6M - $12M annually from ADE reduction, unnecessary test elimination, sepsis improvement, and faster critical result management — across a mid-size health system with 300+ beds.

Implementation Notes¶

Drug interaction knowledge base must be clinically curated and regularly updated; commercial databases (First Databank, Medi-Span) provide the foundation
Alert fatigue reduction requires analysis of historical alert override patterns to identify which alerts are consistently overridden and can be safely suppressed
Clinical pathway content must be developed with physician leadership and approved by the medical staff; AI surfaces deviations, but clinical judgment drives decisions
Sepsis prediction models require real-time vital sign feeds from bedside monitors and nurse charting; EHR integration via HL7/FHIR is standard
All CDS interventions must be approved by the pharmacy and therapeutics (P&T) committee and medical informatics leadership

← Back to Catalogue | Previous: Patient 360 | Next: Revenue Cycle →